Clinical Trial Update: Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to assess the safety and tolerability of Tafasitamab in adults with primary autoimmune blood cell disorders, including immune thrombocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Monjuvi (tafasitamab) (tafasitamab)

Snippet

Sponsor: Incyte Corporation | Conditions: Immune Thrombocytopenia | Phase 2 | Status: RECRUITING